DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹9,360 Cr | ₹7,845 Cr | ₹7,767 Cr | ₹895,983 Cr | ₹6,969 Cr |
What is the latest Revenue of DIVIS LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹9,360 Cr |
| Mar2025 | ₹7,845 Cr |
| Mar2024 | ₹7,767 Cr |
| Mar2023 | ₹895,983 Cr |
| Mar2022 | ₹6,969 Cr |
How is Revenue of DIVIS LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹9,360 Cr | 19.31 | |
| Mar2025 | ₹7,845 Cr | 1.00 | |
| Mar2024 | ₹7,767 Cr | -99.13 | |
| Mar2023 | ₹895,983 Cr | 12,755.96 | |
| Mar2022 | ₹6,969 Cr | - | |
Compare Revenue of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹307,183.5 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
| MANKIND PHARMA | ₹109,911.0 Cr | 4% | 7.5% | 5.8% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 10.5% |
18% |
51.4% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses